Researchers from Erasmus University Medical Center Cancer Institute Describe Research in Breast Cancer (Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients).

Předmět:	ACADEMIC medical centers NEOADJUVANT chemotherapy BREAST cancer research CANCER patients RESEARCH institutes
Zdroj:	Women's Health Weekly; 10/17/2023, p977-977, 1p
Abstrakt:	Keywords: Anthracyclines; Antibiotics; Aromatic Polycyclic Hydrocarbons; Breast Cancer; Cancer; Chemotherapy; Drugs and Therapies; Health and Medicine; Hydrocarbons; Naphthacenes; Oncology; Women's Health EN Anthracyclines Antibiotics Aromatic Polycyclic Hydrocarbons Breast Cancer Cancer Chemotherapy Drugs and Therapies Health and Medicine Hydrocarbons Naphthacenes Oncology Women's Health 977 977 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on breast cancer have been published. For more information on this research see: Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients. npj Breast Cancer, 2023,9(1):1-7. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu